Most-cited are based on citations from 2022 ~ 2024.
-
Original Articles
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- Clin Mol Hepatol. 2023;29(3):721-732.
-
Guideline
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- Clin Mol Hepatol. 2022;28(4):583-705.
-
Reviews
Global incidence and prevalence of nonalcoholic fatty liver disease
- Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
- Clin Mol Hepatol. 2023;29(Suppl):S32-S42.
-
Original Articles
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
- Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):841-850.
-
Reviews
MAFLD: How is it different from NAFLD?
- Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
- Clin Mol Hepatol. 2023;29(Suppl):S17-S31.
-
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
- Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
- Clin Mol Hepatol. 2022;28(2):150-163.
-
Original Articles
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
- Ansel Shao Pin Tang, Kai En Chan, Jingxuan Quek, Jieling Xiao, Phoebe Tay, Margaret Teng, Keng Siang Lee, Snow Yunni Lin, May Zin Myint, Benjamin Tan, Vijay K Sharma, Darren Jun Hao Tan, Wen Hui Lim, Apichat Kaewdech, Daniel Huang, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J Sanyal, Mark Muthiah, Cheng Han Ng
- Clin Mol Hepatol. 2022;28(3):483-496.
-
Reviews
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
- Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):790-801.
-
Original Articles
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
- Cheng Han Ng, Kai En Chan, Yip Han Chin, Rebecca Wenling Zeng, Pei Chen Tsai, Wen Hui Lim, Darren Jun Hao Tan, Chin Meng Khoo, Lay Hoon Goh, Zheng Jye Ling, Anand Kulkarni, Lung-Yi Loey Mak, Daniel Q Huang, Mark Chan, Nicholas WS Chew, Mohammad Shadab Siddiqui, Arun J. Sanyal, Mark Muthiah
- Clin Mol Hepatol. 2022;28(3):565-574.
-
Guideline
KASL clinical practice guidelines for management of chronic hepatitis B
- Clin Mol Hepatol. 2022;28(2):276-331.
-
Reviews
RNA interference as a novel treatment strategy for chronic hepatitis B infection
- Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
- Clin Mol Hepatol. 2022;28(3):408-424.
-
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
- Kuei-Chuan Lee, Pei-Shan Wu, Han-Chieh Lin
- Clin Mol Hepatol. 2023;29(1):77-98.
-
Original Articles
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
- Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, Ruiqi Zhang, Ivan FN Hung, Wai Kay Seto, Man Fung Yuen
- Clin Mol Hepatol. 2022;28(4):890-911.
-
Reviews
Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
- Sun Woong Kim, Jun Sik Yoon, Minjong Lee, Yuri Cho
- Clin Mol Hepatol. 2022;28(1):17-30.
-
The management of post-transplantation recurrence of hepatocellular carcinoma
- Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin
- Clin Mol Hepatol. 2022;28(1):1-16.
-
Non-alcoholic fatty liver disease: Definition and subtypes
- Seul Ki Han, Soon Koo Baik, Moon Young Kim
- Clin Mol Hepatol. 2023;29(suppl):S5-S16.
-
Original Articles
Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults
- Seogsong Jeong, Yun Hwan Oh, Seulggie Choi, Jooyoung Chang, Sung Min Kim, Joung Sik Son, Gyeongsil Lee, Joseph C Ahn, Dong Hyeon Lee, Bo Kyung Koo, Won Kim, Sang Min Park
- Clin Mol Hepatol. 2022;28(3):510-521.
-
Reviews
Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
- Pil Soo Sung
- Clin Mol Hepatol. 2022;28(3):333-350.
-
Original Articles
Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma
- Jungnam Lee, Young-Joo Jin, Seung Kak Shin, Jung Hyun Kwon, Sang Gyune Kim, Young Ju Suh, Yujin Jeong, Jung Hwan Yu, Jin-Woo Lee, Oh Sang Kwon, Soon Woo Nahm, Young Seok Kim
- Clin Mol Hepatol. 2022;28(2):207-218.
-
Reviews
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
- Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
- Clin Mol Hepatol. 2023;29(2):206-216.
-
Original Articles
Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis
- Joonho Jeong, Jung Woo Shin, Seok Won Jung, Eun Ji Park, Neung Hwa Park
- Clin Mol Hepatol. 2022;28(2):254-264.
-
Reviews
Risk factors in nonalcoholic fatty liver disease
- Eunji Ko, Eileen L. Yoon, Dae Won Jun
- Clin Mol Hepatol. 2023;29(Suppl):S79-S85.
-
Interaction between sarcopenia and nonalcoholic fatty liver disease
- Sae Kyung Joo, Won Kim
- Clin Mol Hepatol. 2023;29(Suppl):S68-S78.
-
Original Articles
Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
- Young Eun Chon, Seong Yong Park, Han Pyo Hong, Donghee Son, Jonghyun Lee, Eileen Yoon, Soon Sun Kim, Sang Bong Ahn, Soung Won Jeong, Dae Won Jun
- Clin Mol Hepatol. 2023;29(1):120-134.
-
Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways
- Seung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju Hee Oh, Hyun Sung Kim
- Clin Mol Hepatol. 2022;28(4):827-840.
-
Reviews
Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound
- Junghoan Park, Jeong Min Lee, Tae-Hyung Kim, Jeong Hee Yoon
- Clin Mol Hepatol. 2022;28(3):362-379.
-
Original Articles
Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease
- Won Sohn, Danbee Kang, Minwoong Kang, Eliseo Guallar, Juhee Cho, Yong-Han Paik
- Clin Mol Hepatol. 2022;28(4):851-863.
-
Reviews
Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
- Mina Komuta
- Clin Mol Hepatol. 2022;28(3):396-407.
-
Special Reviews
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
- Gi-Ae Kim, Joon Ho Moon, Won Kim
- Clin Mol Hepatol. 2023;29(4):831-843.
-
Reviews
The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
- Hae Lim Lee, Sung Won Lee
- Clin Mol Hepatol. 2022;28(2):121-134.